Merck
  • SML2259
All Photos(1)

SML2259

Sigma-Aldrich

ラパチニブ

≥98% (HPLC)

Synonym(s):
ラパチニブ, GD 2016, GSK 572016, GW-572016, GW572016, N-(3-クロロ-4-((3-フルオロフェニル)メトキシ)フェニル)-6-(5-(((2-(メチルスルホニル)エチル)アミノ)メチル)-2-フラニル)-4-キナゾリナミン, N-(3-クロロ-4-((3-フルオロフェニル)メトキシ)フェニル)-6-(5-((2-メチルスルホニルエチルアミノ)メチル)-2-フリル)キナゾリン-4-アミン
Empirical Formula (Hill Notation):
C29H26ClFN4O4S
CAS Number:
Molecular Weight:
581.06
MDL番号:
NACRES:
NA.77

アッセイ

≥98% (HPLC)

形状

powder

white to beige

溶解性

DMSO: 2 mg/mL, clear

保管温度

2-8°C

SMILES string

CS(=O)(CCNCC1=CC=C(C2=CC=C3N=CN=C(C3=C2)NC4=CC=C(C(Cl)=C4)OCC5=CC=CC(F)=C5)O1)=O

InChI

1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)

InChI key

BCFGMOOMADDAQU-UHFFFAOYSA-N

Gene Information

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

1 of 4

This Item
PZ0039SML2589SML3109
Lapatinib ≥98% (HPLC)

Sigma-Aldrich

SML2259

ラパチニブ

Lorlatinib ≥98% (HPLC)

Sigma-Aldrich

PZ0039

Lorlatinib

Dasatinib ≥98% (HPLC)

Sigma-Aldrich

SML2589

ダサチニブ

Afatinib ≥98% (HPLC)

Sigma-Aldrich

SML3109

Afatinib

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

form

powder

form

powder

form

powder

form

powder

color

white to beige

color

white to beige

color

white to beige

color

white to beige

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

storage temp.

room temp

storage temp.

−20°C

storage temp.

2-8°C

Gene Information

human ... EGFR(1956), ERBB2(2064)

Gene Information

-

Gene Information

human ... ABL1(25), BLK(640), EPHA2(1969), FGR(2268), FRK(2444), FYN(2534), HCK(3055), KIT(3815), LCK(3932), LYN(4067), PDGFRB(5159), SRC(6714), SRMS(6725), YES1(7525)

Gene Information

-

生物化学的/生理学的作用

Lapatinib acts as a dual tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR/ErbB1) and human epidermal growth factor receptor 2 (HER2/ErbB2). It competes for its binding site on the tyrosine kinase domain with adenosine triphosphate (ATP). Lapatinib mediates has been studied in vitro in the inhibition of cell growth as well as and apoptosis induction in several human cancer cells such as breast, lung, vulva, gastric, and head and neck cancer.

ピクトグラム

Exclamation mark

シグナルワード

Warning

危険有害性情報

危険有害性の分類

Aquatic Chronic 4 - Eye Irrit. 2 - Lact.

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

More Documents

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service